The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin, at the American Heart Association Scientific ...
KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...
Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, ...
Small, gradual lifestyle changes like increasing aerobic exercise, losing weight and eating a healthy diet can reduce your ...
November marks American Diabetes Month, with healthcare providers, public health agencies, educators and community ...
With 29 million people in the U.S. who have diabetes, and another staggering 9.7 million more undiagnosed, according to the ...
“The technology is now changing people’s lives,” Shen said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback